Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Parkkonen, E. Moilanen, H. Kankaanranta (Tampere, Finland). Inhibitors of PDE4 delay eosinophil apoptosis. Eur Respir J 2005; 26: Suppl. 49, 3048

Member's Comments

No comment yet.

Related content which might interest you: Airway inflammation: assessment of neutrophil apoptosis in induced sputum Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia Source: Eur Respir J 2009; 33: 252-262 Year: 2009 Reduced eosinophil apoptosis in induced sputum correlates with asthma severity Source: Eur Respir J 2003; 22: 484-490 Year: 2003 Inflammatory cell activation in eosinophilic and non-eosinophilic asthma Source: Annual Congress 2006 - Immunology of the airways Year: 2006 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003 Selective decoy-mediated inhibition of activator protein-1 activity in the airways prevents experimental asthmatic inflammation Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005 Local application of FTY720 to the lung abrogates experimental asthma by altering myeloid dendritic cell function Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006 Inhibitors of apoptosis proteins in asthmatic airway inflammation Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans Source: International Congress 2015 – Advances in the future treatment of COPD Year: 2015 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD Source: Annual Congress 2005 - Protease-antiprotease revisited Year: 2005 Role of Rho kinase isoforms in murine allergic airway responses Source: Eur Respir J 2011; 38: 841-850 Year: 2011 Ceramide-1-phosphate decreases allergic airway inflammation, remodeling and hyperresponsiveness by inhibition of phosphorilation of NF-kappa B, Akt, MAPK p-38 in dendritic cells Source: Annual Congress 2010 - Models of airways disease Year: 2010 HIF-1α inhibitor, 2ME2, attenuates airway inflammation and hyperresponsiveness in allergic airway disease Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis Source: Eur Respir J 2003; 21: 925-931 Year: 2003 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011